Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

243
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
243
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

332
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
332

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dendrocin ZM1 Nanoconjugates with Carbon Quantum Dots: A ROS-Generating Platform for Combating Multidrug-Resistant Bacteria.

International journal of nanomedicine·2026
Same author

An Investigation of Colistin Heteroresistance in <i>Klebsiella pneumoniae</i> Isolates in Iran.

BioMed research international·2026
Same author

Genetic diversity of <i>Staphylococcus aureus</i> isolated from hospital wastewaters<i>: spa</i> types t747 and t790 are a serious threat.

Journal of water and health·2026
Same author

Alarming colistin and carbapenem resistance in Klebsiella pneumoniae: molecular insights from Tehran hospitals, Iran.

BMC research notes·2025
Same author

Antimicrobial susceptibilities and genomic characteristics of mupirocin resistant Staphylococcus aureus isolates from Tehran, Iran.

Acta microbiologica et immunologica Hungarica·2025
Same author

Detection of Colistin Heteroresistance in Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Clinical Isolates in Iran.

International journal of microbiology·2025
Same journal

Preventable yet persistent: silicosis and gaps in public health policy - a narrative review.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2026
Same journal

Takotsubo syndrome due to occupational stress in a physician.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2026
Same journal

Spirometry after treatment completion for pulmonary tuberculosis - a necessity?

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2026
Same journal

Heart failure at the crossroads of climate change and environmental health: emerging risks, mechanistic insights, and future directions.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2026
Same journal

Aspiration pneumonia in stroke survivors: prevalence and clinical associations at Bolan Medical Complex.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2026
Same journal

The silent fractures: unmasking osteoporosis in south Indian chronic obstructive pulmonary disease patients.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2026
See all related articles

Related Experiment Video

Updated: Jul 5, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.1K

Multidrug-resistant tuberculosis in Iran: a multicenter study.

Fatemeh Khelghati1, Fatemeh Nasirpour Seilakhori1, Mehdi Goudarzi1

  • 1Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran.

Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|January 12, 2024
PubMed
Summary
This summary is machine-generated.

Multidrug-resistant tuberculosis (MDR-TB) is a growing global concern. A study in Iran found a low MDR-TB prevalence of 0.6% among pulmonary TB patients, highlighting the need for improved diagnostics and treatment strategies.

More Related Videos

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.7K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.6K

Related Experiment Videos

Last Updated: Jul 5, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.1K
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.7K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.6K

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Multidrug-resistant tuberculosis (MDR-TB) presents a significant global health challenge.
  • Iran faces a growing incidence of MDR-TB, yet current research on its prevalence in pulmonary TB patients is limited.
  • Effective control strategies require up-to-date data on drug resistance patterns.

Purpose of the Study:

  • To determine the prevalence of MDR-TB among patients with pulmonary tuberculosis in Iran.
  • To identify potential factors contributing to the rise of TB and MDR-TB in the country.
  • To inform the development of improved treatment and diagnostic approaches.

Main Methods:

  • A cross-sectional study involving 1216 respiratory samples from five regional TB laboratories in Iran.
  • Mycobacterium tuberculosis identification using IS6110-based PCR and Xpert MTB/RIF assays.
  • Drug susceptibility testing (DST) performed using the conventional proportion method.

Main Results:

  • Out of 448 positive M. tuberculosis isolates, 445 (99.4%) were susceptible to tested drugs.
  • Only 3 isolates (0.6%) were identified as multidrug-resistant (MDR).
  • The study established a current MDR-TB prevalence of 0.6% in the studied Iranian population.

Conclusions:

  • The prevalence of MDR-TB in Iran is currently low at 0.6%.
  • Inadequate laboratory infrastructure for DST and lack of updated treatment protocols may contribute to potential increases in MDR-TB.
  • Enhancing treatment management and adopting new technologies are crucial for combating TB and MDR-TB in Iran.